videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          id
        }
      }
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    title
    slug
    lang
    htmlBody
    ... on Video {
      imgUrl
      videoUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ... on Webcast {
      imgUrl
      videoUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    id
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

first

order

upcoming

edges

Faron Pharmaceuticals

The agenda is as follows: Opening remarks Faron's strategy and key focus areas - Dr. Juho Jalkanen, MD, PhD, CEO BEXMAB clinical data - Dr. Mika Kontro, MD, PhD, principal investigator of the...

<p>The agenda is as follows:</p>
<ul>
<li>Opening remarks</li>
<li>Faron&apos;s strategy and key focus areas - Dr. Juho Jalkanen, MD, PhD, CEO</li>
<li>BEXMAB clinical data - Dr. Mika Kontro, MD, PhD, principal investigator of the BEXMAB trial</li>
<li>BEXMAB MDS market assessment - Mr. Ralph Hughes, MSc, BSc</li>
<li>Faron&apos;s development plan for solid tumors - Dr. Petri Bono, MD, PhD, CMO</li>
<li>Who benefits from bexmarilimab and why - Future Addressable Markets - Dr. Maija Hollm&#xe9;n, PhD, CSO</li>
<li>Q&amp;A session</li>
<li>Closing remarks</li>
</ul>
<p>More information regarding <a href="https://otp.tools.investis.com/clients/uk/faron2/rns/regulatory-story.aspx?newsid=1872424&amp;cid=2223" target="_blank" rel="noopener">Faron Pharmaceuticals CMD 2024</a></p>

Inderes

Faron Pharmaceuticals Capital Markets Day 2024

Nanoform Finland

Nanoform, Audiocast with teleconference, Q3'24

ALK-Abelló

ALK – Opdatering på de første 9 måneder i 2024 og ny strategisk licensaftale med ARS Pharma

Stay up to date with our newsletter